U.S. Physical Therapy Q2 Earnings Call Highlights
U.S. Physical Therapy NYSE: USPH reported second-quarter 2026 revenue growth supported by higher patient volumes, improved reimbursement rates and the early rollout of hospital-affiliation agreements, while elevated employee healthcare claims and upfront staffing costs pressured physical therapy margins.
U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript
U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript
U.S. Physical Therapy Continues To Heal
U.S. Physical Therapy, Inc. remains rated Hold as operational growth is offset by disappointing profitability and fair valuation. USPH exceeded revenue expectations in Q2 2026, but EPS fell short due to one-time events and rising costs. Clinic expansion, hospital affiliations, and industrial injury prevention services are driving top-line growth and future margin improvement.
U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.75 per share, missing the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.81 per share a year ago.
U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for U.S. Physical Therapy (USPH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid.
U.S. Physical Therapy, Inc. (USPH) Q1 2026 Earnings Call Transcript
U.S. Physical Therapy, Inc. (USPH) Q1 2026 Earnings Call Transcript
U.S. Physical Therapy (USPH) Q1 Earnings and Revenues Lag Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.46 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.48 per share a year ago.
Here's What Key Metrics Tell Us About U.S. Physical Therapy (USPH) Q1 Earnings
While the top- and bottom-line numbers for U.S. Physical Therapy (USPH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Analysts Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $104.50
U.S. Physical Therapy, Inc. (NYSE: USPH - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy
Wall Street Analysts Believe U.S. Physical Therapy (USPH) Could Rally 26.52%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in U.S. Physical Therapy (USPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
U.S. Physical Therapy, Inc. (USPH) Q4 2025 Earnings Call Transcript
U.S. Physical Therapy, Inc. (USPH) Q4 2025 Earnings Call Transcript
